Growth hormone insensitivity syndrome associated with syringomyelia and type I chiari malformation

Internal Medicine

Volumn 42, Issue 11, 2003, Pages 1117-1121

  Takagi, Junko ^a   Otake, Kazuo ^a   Takahashi, Masahiko ^a   Nakao, Naoki ^a   Hirooka, Yoshifumi ^a   Sahashi, Ko ^a   Nogimori, Tsuyoshi ^b  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Konanshowa Hospital   (Japan)

Author keywords

Chiari I; Growth hormone insensitivity syndrome; Syringomyelia

Indexed keywords

DNA; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; GROWTH HORMONE RELEASING FACTOR; LEVODOPA; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; CASE REPORT; CHIARI FROMMEL SYNDROME; COMORBIDITY; CONCENTRATION RESPONSE; DNA SEQUENCE; ENDOCRINE DISEASE; GENE DELETION; GENE MUTATION; GENETIC POLYMORPHISM; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE INSENSITIVITY SYNDROME; HUMAN; MALE; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; SHORT STATURE; SYRINGOMYELIA;

EID: 0347513385     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.42.1117     Document Type: Article

References (23)

1. Pirinen S, Majurin A, Lenko HL, Koski K. Craniofacial features in patients with deficient and excessive growth hormone. J Craniofac Genet Dev Biol 14: 144-152, 1994.
2. Kornreich L, Horev G, Schwarz M, Katmazyn B, Laron Z. Craniofacial and brain abnormalities in Laron syndrome (primary growth hormone insensitivity). Eur J Endocrinol 146: 499-503, 2002.
3. Simmons KE. Growth hormone and craniofacial changes: Preliminary data from studies in Turner's syndrome. Pediatrics 104: 1021-1024, 1999.
4. Milhorat TH, Capocelli AL Jr, Anzil AP, Kotzen RM, Milhorat RH. Pathological basis of spinal cord cavitation in syringomyelia: analysis of 105 autopsy cases. J Neurosurg 82: 802-812, 1995.
5. Mukai E, Mori O. Pituitary dwarfism and syringomyelia. Shinkei Naika (Neurol Med) 39: 331-340, 1993 (in Japanese).
6. Koga T, Abe T, Noriyuki H, Iwatani N, Otsuka T. Isolated partial growth hormone deficient short stature with syringomyelia not associated with birth injury. Internal Med 37: 674-677, 1998.
7. Marwaha R, Menon PS, Jena A, Pant C, Sethi AK, Sapra ML. Hypothalamo-pituitary axis by magnetic resonance imaging in isolated growth hormone deficiency patients born by normal delivery. J Clin Endocrinol Metab 74: 654-659, 1992.
8. Kaji H, Nose O, Tajiri H, et al. Novel compound heterozygous mutations of the growth hormone (GH) receptor gene in a patient with GH insensitivity syndrome. J Clin Endocrinol Metab 82: 3705-3709, 1997.
9. Ball WS Jr, Crone KR. Chiari I malformation: from Dr Chiari to MR imaging. Radiology 195: 602-604, 1995.
10. Heiss JD, Patronas N, DeVroom, HL, et al. Elucidating the pathophysiology of syringomyelia. J Neurosurg 91: 553-562, 1999.
11. Reuck DJ, Alva J, Roels H, Vander Eecken H. Relation between syringomyelia and von-Hippel-Lindau's disease. Eur Neurol 12: 116-127, 1974.
12. Sari A, Demirci A. Radiographic type I autosomal dominat osteopetrosis with syringohydromyelia. Neuroradiology 38: 532-533, 1996.
13. Zakeri A, Glasauer FE, Egnatchik JG. Familial syringomyelia: case report and review of the literature. Surg Neurol 44: 48-53, 1995.
14. Cavender RK, Schmidt JH 3rd. Tonsillar ectopia and Chiari malformation: monozygotic triplets. Case report. J Neurosurg 82: 497-500, 1995.
15. Castillo M, Wilson JD. Spontaneous resolution of a Chiari malformation: MR demonstration. AJNR 16: 1158-1160, 1995.
16. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone-a new inborn error of metabolism? Isr J Med Sci 2: 152-155, 1966.
17. Amselem S, Duquesnoy P, Attree O, et al. Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med 321: 989-995, 1989.
18. Godowski PJ, Leung DW, Meacham LR, et al. Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Nat Acad Sci (USA) 86: 8083-8087, 1989.
19. Woods KA, Fraser NC, Postel-Vinay MC, Savage MO, Clark AJ. A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J Clin Endocrinol Metab 81: 1686-1690, 1996.
20. Berg MA, Argente J, Chernausek S, et al. Diverse growth hormone receptor gene mutations in Laron syndrome. Am J Hum Genet 52: 998-1005, 1993.
21. Freeth JS, Ayling RM, Whatmore AJ, et al. Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome. Endocrinology 138: 55-61, 1997.
22. Freeth JS, Silva CM, Whatmore AJ, Clayton PE. Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron syndrome children. Endocrinology 139: 20-28, 1998.
23. Woods KA, Camacho-Hübner C, Savage MO, Clark AJ. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335: 1363-1367, 1996.